Concepedia

Publication | Open Access

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

DOIFull Paper Access

44

Citations

23

References

2022

Year

Pengfei Jin, Xiling Guo, Wei Chen, Shi-Hua Ma, Hongxing Pan, Lianpan Dai, Pan Du, Lili Wang, Lairun Jin, Yin Chen,
PLoS Medicine

Abstract

Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine; ClinicalTrial.gov NCT04833101.

References

YearCitations

Page 1